Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001294246 | SCV001483116 | uncertain significance | Familial aplasia of the vermis; Meckel-Gruber syndrome; Nephronophthisis | 2021-09-01 | criteria provided, single submitter | clinical testing | This sequence change replaces asparagine with tyrosine at codon 212 of the CEP290 protein (p.Asn212Tyr). The asparagine residue is moderately conserved and there is a large physicochemical difference between asparagine and tyrosine. This variant is present in population databases (rs527704077, ExAC 0.006%). This variant has not been reported in the literature in individuals affected with CEP290-related conditions. Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Deleterious"; PolyPhen-2: "Probably Damaging"; Align-GVGD: "Class C0"). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
Molecular Endocrinology Laboratory, |
RCV001823768 | SCV002073504 | uncertain significance | Bardet-Biedl syndrome 14 | criteria provided, single submitter | clinical testing | ||
Natera, |
RCV001830116 | SCV002094930 | uncertain significance | Leber congenital amaurosis | 2021-05-25 | no assertion criteria provided | clinical testing |